Review
doi: 10.1159/000071369.
Cyclooxygenase-2: a target for the prevention and treatment of cancers of the upper digestive tract
Affiliations
- PMID: 12795051
- DOI: 10.1159/000071369
Item in Clipboard
Review
Cyclooxygenase-2: a target for the prevention and treatment of cancers of the upper digestive tract
Prog Exp Tumor Res.
2003.
No abstract available
Similar articles
-
COX-2: a target for prevention and treatment of esophageal cancer.J Surg Res. 2004 Mar;117(1):114-20. doi: 10.1016/j.jss.2003.12.005. J Surg Res. 2004. PMID: 15013721 Review. No abstract available.
-
Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus.J Natl Cancer Inst. 2002 Mar 20;94(6):406-7. doi: 10.1093/jnci/94.6.406. J Natl Cancer Inst. 2002. PMID: 11904306 No abstract available.
-
Cyclooxygenase-2 in lung cancer.Prog Exp Tumor Res. 2003;37:138-62. doi: 10.1159/000071371. Prog Exp Tumor Res. 2003. PMID: 12795053 Review. No abstract available.
-
Cyclooxygenase-2 and skin carcinogenesis.Prog Exp Tumor Res. 2003;37:72-89. doi: 10.1159/000071367. Prog Exp Tumor Res. 2003. PMID: 12795049 Review. No abstract available.
-
Cyclooxygenase-2 inhibitors and atherosclerosis.J Am Coll Cardiol. 2003 May 21;41(10):1820-2. doi: 10.1016/s0735-1097(03)00305-x. J Am Coll Cardiol. 2003. PMID: 12767670 No abstract available.
Cited by
-
Analysis of Cox-2 and thromboxane synthase expression in pituitary adenomas and carcinomas.Endocr Pathol. 2004 Spring;15(1):17-27. doi: 10.1385/ep:15:1:17. Endocr Pathol. 2004. PMID: 15067173
-
HSP90 Inhibition Suppresses PGE2 Production via Modulating COX-2 and 15-PGDH Expression in HT-29 Colorectal Cancer Cells.Inflammation. 2016 Jun;39(3):1116-23. doi: 10.1007/s10753-016-0343-1. Inflammation. 2016. PMID: 27075590
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
